213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
Crossref DOI link: https://doi.org/10.1007/s00259-014-2857-9
Published Online: 2014-07-29
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kratochwil, C.
Giesel, F. L.
Bruchertseifer, F.
Mier, W.
Apostolidis, C.
Boll, R.
Murphy, K.
Haberkorn, U.
Morgenstern, A.
Text and Data Mining valid from 2014-07-29
Version of Record valid from 2014-07-29
Article History
Received: 31 March 2014
Accepted: 3 July 2014
First Online: 29 July 2014